- Discuss the role of pathophysiology, biomarkers, and genetic factors in the diagnosis and treatment of Alzheimer disease.
- Evaluate the role of monoclonal antibodies in the treatment of Alzheimer disease.
- Assess strategies and data for long-term management of Alzheimer disease.
Clinical Staging, Biomarkers, and Treatments for Alzheimer Disease
Monday, June 2, 2025
7:00 PM - 8:30 PM
Virtual
OVERVIEW
NeurologyLive® Clinical Forum are regional roundtable discussions where an expert moderator has the opportunity to directly engage with neurologists to present data, medical advances, and patient case scenarios. This leads to a moderated forum between attendees to gather insights on their community practice implementation of new science, feedback on case scenarios, as well as other information which impact the clinical decision making of local neurologists.
These forums serve as a platform for localized education and peer-to-peer collaborative discussions aiming to ultimately elevate and improve patient care.
LEARNING OBJECTIVES
Venue Location
Virtual
MARKET RESEARCH PARTICIPATION
This event is held in partnership with Healthcare Research & Analytics® to gain market research insights into health care professional’s educational needs in their current practice setting.
HR&A offers compensation of $500 to physicians for your consultative contributions during the event discussions, responses to polling questions and completion of a post-event survey.
Refer a physician colleague for a $150 bonus courtesy of NeurologyLive®. Please note both you and your colleague must attend and complete the postevent survey in order to receive the bonus.
Copyright NeurologyLive 2025.
All Rights Reserved.
Privacy Policy
Contact Us: events@neurologylive.com